United States · FDA National Drug Code directory
Trileptal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0337_dcd739ce-e938-40e6-8912-ca4f34b49cf3
- Product NDC
- 0078-0337
- Form
- TABLET, FILM COATED
- Composition / generic term
- oxcarbazepine
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20000130
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (0078-0337-05) · 0078-0337-05
- 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0337-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0337-61) · 0078-0337-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →